tirzepatide and hormone replacement therapy Tirzepatide, Combination Increases Weight Loss in Postmenopausal Women A small but powerful study

The trial demonstrated that oral semaglutide was non-inferior to placebo in this aspect

Sedky AA, Magdy Y

Answer: Glucagon-like peptide-1 (GLP-1) receptor agonists, a class of medications that includes semaglutide (Wegovy, Ozempic, Rybelsus), tirzepatide (Zepbound, Mounjaro), liraglutide (Victoza, Saxenda), and orforglipron (Foundayo), have become increasingly popular for obesity treatment (Mehrtash, JAMA Intern Med 2025)

Therefore, both excessive activation and inhibition of Nrf2 may be detrimental to DOX-induced cardiomyopathy

FDA Drug Safety Communication: Risk of oral clefts in children born to mothers taking Topamax (topiramate)